drugset / Trial / NCT04742348

Research on Translational Outcomes of Alcohol (Project RETRO)

NCT04742348 ↗

Phase 4 Withdrawn University of Washington
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary aim of the current study is to assess the effect of a single dose of carbidopa-levodopa on ad libitum alcohol consumption and alcohol craving in young adults with a history of binge drinking.

Timeline

Start
2023-02
Primary completion
2023-08
Completion
2023-08

Outcome

Outcome not reported

Stopped (Business): “COVID-19 and expiration of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 50 mg —
Subject Levodopa Unknown 500 mg —